Always up to date.
 

Our goal is to develop procedure and anatomy specific devices that lead in collaboration with our customers to predictable and superior treatment outcomes. Read on to learn more about our solutions, priorities, partnerships and how we create sustainable value with our teams.

Medartis on track with 16% internal growth after 6 months

Medartis reported half-year sales of CHF 103.3 million, representing growth of 20.8% at CER. Internal growth amounted to 16.1%.The EMEA business made the largest contribution to this growth with an...

Read more